Trigeminal Neuralgia Treatment Market 2027 by Drug Type, Surgery | The Insight Partners

Trigeminal Neuralgia Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Drug Type (Anticonvulsant, NSAIDs, Opioids); Surgery (Rhizotomy, Stereotactic Radiosurgery, Microvascular Decompression)

Report Code: TIPRE00008477 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Covid
MARKET INTRODUCTION

Trigeminal neuralgia is a condition of chronic pain that affects the trigeminal nerve that carries sensation from your face to your brain. If the person is suffering from trigeminal neuralgia, even mild stimulation in the face such as brushing teeth or putting on makeup may trigger intense pain.

MARKET DYNAMICS

The trigeminal neuralgia treatment market is anticipated to increase due to the advancement of new technology and growing public awareness about the disease. However, surgeries associated with trigeminal neuralgia treatment and technical complexities related to diagnostic test may restrain the market growth. Moreover, the rising geriatric population in the market for trigeminal neuralgia treatment is experiencing a significant increase that drives the market.

MARKET SCOPE

The "Trigeminal Neuralgia Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of in trigeminal neuralgia treatment market with detailed market segmentation by drug type, surgery and geography. The trigeminal neuralgia treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading in trigeminal neuralgia treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The trigeminal neuralgia treatment market is segmented on the basis of drug type, and surgery. Based on drug type the market is segmented as anticonvulsant, NSAIDs and opioids. On the basis of surgery the market is categorized as rhizotomy, stereotactic radiosurgery and microvascular decompression.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the in trigeminal neuralgia treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The trigeminal neuralgia treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting trigeminal neuralgia treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the trigeminal neuralgia treatment market in these regions.




Get more information on this report :

MARKET PLAYERS


The report covers key developments in the in trigeminal neuralgia treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from in trigeminal neuralgia treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for in trigeminal neuralgia treatment market in the global market. Below mentioned is the list of few companies engaged in the trigeminal neuralgia treatment market.

The report also includes the profiles of key in trigeminal neuralgia treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

- Abbott Laboratories
- Allergan Plc
- Biogen
- Bio-Rad Laboratories, Inc.
- GlaxoSmithKline plc
- Merz Pharma GmbH & Co.,
- Novartis AG
- Ortho Clinical Diagnostics
- Pfizer Inc.
- Trigemina Inc.

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Trigeminal Neuralgia Treatment Market - By Drug Type
1.3.2 Trigeminal Neuralgia Treatment Market - By Surgery
1.3.3 Trigeminal Neuralgia Treatment Market - By Region
1.3.3.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. TRIGEMINAL NEURALGIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. TRIGEMINAL NEURALGIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. TRIGEMINAL NEURALGIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. TRIGEMINAL NEURALGIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. TRIGEMINAL NEURALGIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. TRIGEMINAL NEURALGIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DRUG TYPE
7.1. OVERVIEW
7.2. DRUG TYPE MARKET FORECASTS AND ANALYSIS
7.3. ANTICONVULSANT
7.3.1. Overview
7.3.2. Anticonvulsant Market Forecast and Analysis
7.4. NSAIDS
7.4.1. Overview
7.4.2. NSAIDs Market Forecast and Analysis
7.5. OPIOIDS
7.5.1. Overview
7.5.2. Opioids Market Forecast and Analysis
8. TRIGEMINAL NEURALGIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - SURGERY
8.1. OVERVIEW
8.2. SURGERY MARKET FORECASTS AND ANALYSIS
8.3. RHIZOTOMY
8.3.1. Overview
8.3.2. Rhizotomy Market Forecast and Analysis
8.4. STEREOTACTIC RADIOSURGERY
8.4.1. Overview
8.4.2. Stereotactic Radiosurgery Market Forecast and Analysis
8.5. MICROVASCULAR DECOMPRESSION
8.5.1. Overview
8.5.2. Microvascular Decompression Market Forecast and Analysis
9. TRIGEMINAL NEURALGIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Trigeminal Neuralgia Treatment Market Overview
9.1.2 North America Trigeminal Neuralgia Treatment Market Forecasts and Analysis
9.1.3 North America Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Drug Type
9.1.4 North America Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Surgery
9.1.5 North America Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Trigeminal Neuralgia Treatment Market
9.1.5.1.1 United States Trigeminal Neuralgia Treatment Market by Drug Type
9.1.5.1.2 United States Trigeminal Neuralgia Treatment Market by Surgery
9.1.5.2 Canada Trigeminal Neuralgia Treatment Market
9.1.5.2.1 Canada Trigeminal Neuralgia Treatment Market by Drug Type
9.1.5.2.2 Canada Trigeminal Neuralgia Treatment Market by Surgery
9.1.5.3 Mexico Trigeminal Neuralgia Treatment Market
9.1.5.3.1 Mexico Trigeminal Neuralgia Treatment Market by Drug Type
9.1.5.3.2 Mexico Trigeminal Neuralgia Treatment Market by Surgery
9.2. EUROPE
9.2.1 Europe Trigeminal Neuralgia Treatment Market Overview
9.2.2 Europe Trigeminal Neuralgia Treatment Market Forecasts and Analysis
9.2.3 Europe Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Drug Type
9.2.4 Europe Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Surgery
9.2.5 Europe Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Trigeminal Neuralgia Treatment Market
9.2.5.1.1 Germany Trigeminal Neuralgia Treatment Market by Drug Type
9.2.5.1.2 Germany Trigeminal Neuralgia Treatment Market by Surgery
9.2.5.2 France Trigeminal Neuralgia Treatment Market
9.2.5.2.1 France Trigeminal Neuralgia Treatment Market by Drug Type
9.2.5.2.2 France Trigeminal Neuralgia Treatment Market by Surgery
9.2.5.3 Italy Trigeminal Neuralgia Treatment Market
9.2.5.3.1 Italy Trigeminal Neuralgia Treatment Market by Drug Type
9.2.5.3.2 Italy Trigeminal Neuralgia Treatment Market by Surgery
9.2.5.4 Spain Trigeminal Neuralgia Treatment Market
9.2.5.4.1 Spain Trigeminal Neuralgia Treatment Market by Drug Type
9.2.5.4.2 Spain Trigeminal Neuralgia Treatment Market by Surgery
9.2.5.5 United Kingdom Trigeminal Neuralgia Treatment Market
9.2.5.5.1 United Kingdom Trigeminal Neuralgia Treatment Market by Drug Type
9.2.5.5.2 United Kingdom Trigeminal Neuralgia Treatment Market by Surgery
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Trigeminal Neuralgia Treatment Market Overview
9.3.2 Asia-Pacific Trigeminal Neuralgia Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Drug Type
9.3.4 Asia-Pacific Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Surgery
9.3.5 Asia-Pacific Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Trigeminal Neuralgia Treatment Market
9.3.5.1.1 Australia Trigeminal Neuralgia Treatment Market by Drug Type
9.3.5.1.2 Australia Trigeminal Neuralgia Treatment Market by Surgery
9.3.5.2 China Trigeminal Neuralgia Treatment Market
9.3.5.2.1 China Trigeminal Neuralgia Treatment Market by Drug Type
9.3.5.2.2 China Trigeminal Neuralgia Treatment Market by Surgery
9.3.5.3 India Trigeminal Neuralgia Treatment Market
9.3.5.3.1 India Trigeminal Neuralgia Treatment Market by Drug Type
9.3.5.3.2 India Trigeminal Neuralgia Treatment Market by Surgery
9.3.5.4 Japan Trigeminal Neuralgia Treatment Market
9.3.5.4.1 Japan Trigeminal Neuralgia Treatment Market by Drug Type
9.3.5.4.2 Japan Trigeminal Neuralgia Treatment Market by Surgery
9.3.5.5 South Korea Trigeminal Neuralgia Treatment Market
9.3.5.5.1 South Korea Trigeminal Neuralgia Treatment Market by Drug Type
9.3.5.5.2 South Korea Trigeminal Neuralgia Treatment Market by Surgery
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Trigeminal Neuralgia Treatment Market Overview
9.4.2 Middle East and Africa Trigeminal Neuralgia Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Drug Type
9.4.4 Middle East and Africa Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Surgery
9.4.5 Middle East and Africa Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Trigeminal Neuralgia Treatment Market
9.4.5.1.1 South Africa Trigeminal Neuralgia Treatment Market by Drug Type
9.4.5.1.2 South Africa Trigeminal Neuralgia Treatment Market by Surgery
9.4.5.2 Saudi Arabia Trigeminal Neuralgia Treatment Market
9.4.5.2.1 Saudi Arabia Trigeminal Neuralgia Treatment Market by Drug Type
9.4.5.2.2 Saudi Arabia Trigeminal Neuralgia Treatment Market by Surgery
9.4.5.3 U.A.E Trigeminal Neuralgia Treatment Market
9.4.5.3.1 U.A.E Trigeminal Neuralgia Treatment Market by Drug Type
9.4.5.3.2 U.A.E Trigeminal Neuralgia Treatment Market by Surgery
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Trigeminal Neuralgia Treatment Market Overview
9.5.2 South and Central America Trigeminal Neuralgia Treatment Market Forecasts and Analysis
9.5.3 South and Central America Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Drug Type
9.5.4 South and Central America Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Surgery
9.5.5 South and Central America Trigeminal Neuralgia Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Trigeminal Neuralgia Treatment Market
9.5.5.1.1 Brazil Trigeminal Neuralgia Treatment Market by Drug Type
9.5.5.1.2 Brazil Trigeminal Neuralgia Treatment Market by Surgery
9.5.5.2 Argentina Trigeminal Neuralgia Treatment Market
9.5.5.2.1 Argentina Trigeminal Neuralgia Treatment Market by Drug Type
9.5.5.2.2 Argentina Trigeminal Neuralgia Treatment Market by Surgery
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. TRIGEMINAL NEURALGIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. ABBOTT LABORATORIES
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALLERGAN PLC
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. BIOGEN
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. BIO-RAD LABORATORIES, INC.
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. GLAXOSMITHKLINE PLC
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MERZ PHARMA GMBH AND CO.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. NOVARTIS AG
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. ORTHO CLINICAL DIAGNOSTICS
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. PFIZER INC.
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. TRIGEMINA INC.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Abbott Laboratories
2. Allergan Plc
3. Biogen
4. Bio-Rad Laboratories, Inc.
5. GlaxoSmithKline plc
6. Merz Pharma GmbH & Co.,
7. Novartis AG
8. Ortho Clinical Diagnostics
9. Pfizer Inc.
10. Trigemina Inc.
TIPRE00008477
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking